| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.4M | -6.6% |
| Cost of Revenue | $4.8M | -9.4% |
| R&D Expense | $1.5M | +399.0% |
| SG&A Expense | $6.9M | +23.5% |
| Operating Income | -$10.2M | -71.9% |
| Interest Expense | $239K | -88.6% |
| Income Tax | $0 | — |
| Net Income | -$10.2M | -14.3% |
| EPS (Basic) | -$1.16 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.3M | -44.8% |
| Accounts Receivable | $1.6M | -46.8% |
| Current Assets | $19.7M | -40.3% |
| Total Assets | $24.6M | -31.1% |
| Current Liabilities | $4.3M | +70.9% |
| Total Liabilities | $4.3M | -27.3% |
| Stockholders' Equity | $20.3M | -31.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | +45.5% |
| Capital Expenditures | $216K | +8351.1% |
| Investing Cash Flow | -$3.2M | -207.5% |
| Financing Cash Flow | -$3.4M | -108.8% |
| Free Cash Flow | -$6.0M | +43.5% |
| +44.5% |
| EPS (Diluted) | -$1.16 | +44.5% |